Report cover image

Abiomed Inc - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Feb 16, 2026
Length 47 Pages
SKU # GBDT20881185

Description

Summary

Abiomed Inc (Abiomed) is a medical device company. It develops innovative heart pump technologies, including the Impella family, which provides temporary hemodynamic support for patients with severe coronary artery disease and heart failure. The company’s product portfolio includes the Impella CP, designed for high-risk PCI procedures and cardiogenic shock, and the Impella 5.5, offering full cardiac support for long-duration use. The Impella RP supports patients with right heart failure. Abiomed offers the Breethe OXY-1 System, a compact cardiopulmonary support device that oxygenates and pumps blood while enabling patient mobility. The company also offers Impella Connect, a cloud-based platform that allows healthcare teams to remotely monitor patient status. Abiomed is headquartered in Danvers, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Abiomed Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

47 Pages
Abiomed Inc Company Overview
Abiomed Inc Company Snapshot
Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
Abiomed Inc – Pipeline Analysis Overview
Business Description
Abiomed Inc - Key Facts
Abiomed Inc - Major Products and Services
Abiomed Inc Pipeline Products by Development Stage
Abiomed Inc Ongoing Clinical Trials by Trial Status
Abiomed Inc Pipeline Products Overview
AbioCor II
AbioCor II Product Overview
Artificial Intelligence Algorithm
Artificial Intelligence Algorithm Product Overview
Artificial Intelligence Algorithm Clinical Trial
Expandable Sheath - Heart Failure
Expandable Sheath - Heart Failure Product Overview
Impecmo
Impecmo Product Overview
Impella BTR
Impella BTR Product Overview
Impella BTR Clinical Trial
Impella ECP
Impella ECP Product Overview
Impella ECP Clinical Trial
Impella XC
Impella XC Product Overview
Impella XR Sheath With Impella CP
Impella XR Sheath With Impella CP Product Overview
Laminar Left Atrial Appendage Closure System
Laminar Left Atrial Appendage Closure System Product Overview
Laminar Left Atrial Appendage Closure System Clinical Trial
Next Generation Impella CP - STEMI
Next Generation Impella CP - STEMI Product Overview
Next Generation Impella CP - STEMI Clinical Trial
Symphony Heart Pump
Symphony Heart Pump Product Overview
Abiomed Inc - Key Competitors
Abiomed Inc - Key Employees
Abiomed Inc - Key Employee Biographies
Abiomed Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Abiomed Inc, Recent Developments
Dec 22, 2025: Blood Pump Controller Correction: Abiomed Updates Use Instructions for Automated Impella Controllers
Oct 28, 2025: Abiomed Receives Additional 510(K) Clearance For 14Fr Low Profile Introducer Set
Oct 24, 2025: Johnson & Johnson MedTech Highlights Newest Impella Heart Pump and Long-Term Survival Data at TCT 2025
Oct 10, 2025: Alert: Automated Impella Controller Correction due to Cybersecurity Issue from Abiomed
Sep 23, 2025: Early Alert: Automated Impella Controller Purge Retainer Fixation Issue from Abiomed
Aug 31, 2025: New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump
Jul 01, 2025: Early Alert: Blood Pump Controller Issue from Abiomed
Mar 27, 2025: Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25
Feb 14, 2025: Heart Pump Recall: Abiomed Updates Use Instructions for Impella RP with SmartAssist and Impella RP Flex with SmartAssist Due to A Risk That the Tip of Guidewires or Other Medical Devices May Come into Contact with The Impella Pump During Insertion, A
Dec 12, 2024: U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
Abiomed Inc Pipeline Products by Equipment Type
Abiomed Inc Pipeline Products by Indication
Abiomed Inc Ongoing Clinical Trials by Trial Status
Abiomed Inc, Key Facts
Abiomed Inc, Major Products and Services
Abiomed Inc Number of Pipeline Products by Development Stage
Abiomed Inc Pipeline Products Summary by Development Stage
Abiomed Inc Ongoing Clinical Trials by Trial Status
Abiomed Inc Ongoing Clinical Trials Summary
AbioCor II - Product Status
AbioCor II - Product Description
Artificial Intelligence Algorithm - Product Status
Artificial Intelligence Algorithm - Product Description
Artificial Intelligence Algorithm - Abiomed IMPELLA-RT-DAQ - Impella Real Time Data Acquisition
Expandable Sheath - Heart Failure - Product Status
Expandable Sheath - Heart Failure - Product Description
Impecmo - Product Status
Impecmo - Product Description
Impella BTR - Product Status
Impella BTR - Product Description
Impella BTR - Use of the Impella BTR in Patients with Heart Failure: An Early Feasibility Study
Impella ECP - Product Status
Impella ECP - Product Description
Impella ECP - Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention: An Early Feasibility Study
Impella XC - Product Status
Impella XC - Product Description
Impella XR Sheath With Impella CP - Product Status
Impella XR Sheath With Impella CP - Product Description
Laminar Left Atrial Appendage Closure System - Product Status
Laminar Left Atrial Appendage Closure System - Product Description
Laminar Left Atrial Appendage Closure System - An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects with Non-Valvular Atrial Fibrillation
Next Generation Impella CP - STEMI - Product Status
Next Generation Impella CP - STEMI - Product Description
Next Generation Impella CP - STEMI - Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
Symphony Heart Pump - Product Status
Symphony Heart Pump - Product Description
Abiomed Inc, Key Employees
Abiomed Inc, Key Employee Biographies
Abiomed Inc, Subsidiaries
Glossary
List of Figures
Abiomed Inc Pipeline Products by Equipment Type
Abiomed Inc Pipeline Products by Development Stage
Abiomed Inc Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us